Please login to the form below

Not currently logged in


This page shows the latest Herpes news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate heads for human studies

Genital herpes vaccine candidate heads for human studies

Genital herpes is an incurable, contagious sexually-transmitted infection caused by Herpes simplex virus-2 (HSV-2) that causes a lifetime of painful outbreaks. ... Worldwide genital herpes affects a massive 400 million people, and it’s widely held that

Latest news

More from news
Approximately 7 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    contain the adjuvant QS-21 Stimulon.  In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.  GSK's malarial vaccine, Mosquirix which also contains

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    10. ‡‡BioAlliance Pharma/ Innocutis. Licence. Sitavig (acyclovir Lauriad) for recurrent herpes labialis (approved).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word